Stephen Yoo, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 30,828 shares at $59.54 ($1.9M) on 2018-10-15, disclosed to the SEC on 2018-10-17.
Open-market sale of $1.9M RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.83 | 2,900 | $171K | 9.1% |
| 2 | $59.54 | 7,000 | $417K | 22.3% |
| 3 | $60.25 | 100 | $6K | 0.3% |
| 4 | $61.18 | 10,414 | $637K | 34.1% |
| 5 | $61.18 | 10,414 | $637K | 34.1% |
| Total | $60.58 avg | 30,828 |
| $1.9M |
| 100% |
| Filing → |
| RGNX | SELL | 2018-11-07 | $2.5M | — | Filing → |
| RGNX | SELL | 2018-10-31 | $2.3M | — | Filing → |
| RGNX | SELL | 2017-09-12 | $684K | — | Filing → |